
Rutocef S 500mg/250mg Injection
Marketer
Zuno Pharmaceuticals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Rutocef S 500mg/250mg Injection
Cefuroxime and Sulbactam injection (500mg/250mg), a dual-action antibiotic, combats bacterial infections by inhibiting microbial growth. Administer this medication strictly as directed by your physician. Complete the prescribed course, even with symptom improvement; premature cessation can compromise effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms or allergic reactions (rash, itching, swelling, respiratory distress) immediately. Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption may increase drowsiness. While driving impairment is uncommon, avoid driving if experiencing dizziness or somnolence. Adequate rest, balanced nutrition, and hydration promote recovery. Your doctor may order blood tests to monitor treatment efficacy.
Uses of Rutocef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Rutocef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rutocef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rutocef S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
How Rutocef S 500mg/250mg Injection works:
Rutocef S Injection, containing 500mg Ceftriaxone and 250mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Rutocef S 500mg/250mg Injection use.
PregnancySAFE IF PRESCRIBED
Rutocef S 500mg/250mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Rutocef S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Rutocef S 500mg/250mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rutocef S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Rutocef S 500mg/250mg Injection cautiously, with potential dose modification. Mild to moderate liver disease does not necessitate Rutocef S 500mg/250mg Injection dose alteration; however, physician consultation is advised for all patients.
What if you forget to take Rutocef S 500mg/250mg Injection :
Omit a scheduled Rutocef S 500mg/250mg Injection? Seek your physician's advice.
Facts to Know About Rutocef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
